In vitro selection of resistant Helicobacter pylori
- PMID: 2285275
- PMCID: PMC171897
- DOI: 10.1128/AAC.34.9.1637
In vitro selection of resistant Helicobacter pylori
Abstract
Four strains of Helicobacter pylori were subjected to an in vitro serial passage technique to compare the propensity of the organisms to develop resistance to seven classes of antibacterial agents. The passages were made on serially doubling concentrations of antibacterial agents incorporated into agar starting at one-half the base-line MIC. The frequency of spontaneous resistance was also determined for each strain at four and eight times the MIC of each antibacterial agent. Strains resistant to ciprofloxacin, metronidazole, erythromycin, and tobramycin were isolated. The experiments failed to select organisms resistant to bismuth subsalicylate, furazolidone, or amoxicillin, although the MIC of amoxicillin was increased 4- to 16-fold. With the exception of erythromycin, organisms with the selected resistance were stable after at least three passages on antibacterial agent-free medium. Spontaneous resistance rates were generally of a low magnitude and were not predictive of the serial passage results.
Similar articles
-
[Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children].Zhonghua Er Ke Za Zhi. 2007 Sep;45(9):708-11. Zhonghua Er Ke Za Zhi. 2007. PMID: 18021568 Chinese.
-
Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications.S Afr Med J. 2010 Jan;100(1):49-52. S Afr Med J. 2010. PMID: 20429489
-
Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.J Chemother. 1996 Feb;8(1):52-4. doi: 10.1179/joc.1996.8.1.52. J Chemother. 1996. PMID: 8835109
-
Changing pattern of antibiotic resistance of Helicobacter pylori in children during 20 years in Jinju, South Korea.Pediatr Int. 2013 Jun;55(3):332-6. doi: 10.1111/ped.12048. Pediatr Int. 2013. PMID: 23279258 Review.
-
Quinone Derivatives as Promising Anti-Helicobacter pylori Agents from Aerial Parts of Mitracarpus hirtus.J Nat Prod. 2022 Apr 22;85(4):1029-1038. doi: 10.1021/acs.jnatprod.1c01163. Epub 2022 Apr 12. J Nat Prod. 2022. PMID: 35412828 Review.
Cited by
-
Role of metronidazole resistance in therapy of Helicobacter pylori infections.Antimicrob Agents Chemother. 1992 Jan;36(1):163-6. doi: 10.1128/AAC.36.1.163. Antimicrob Agents Chemother. 1992. PMID: 1590683 Free PMC article.
-
Third-line rescue therapy for Helicobacter pylori infection.World J Gastroenterol. 2006 Apr 21;12(15):2313-9. doi: 10.3748/wjg.v12.i15.2313. World J Gastroenterol. 2006. PMID: 16688818 Free PMC article. Review.
-
Eradication rate of Helicobcter pylori.Gut. 1995 Oct;37(4):591-2. doi: 10.1136/gut.37.4.591-a. Gut. 1995. PMID: 7489957 Free PMC article. No abstract available.
-
Second-line rescue therapy of helicobacter pylori infection.Therap Adv Gastroenterol. 2009 Nov;2(6):331-56. doi: 10.1177/1756283X09347109. Therap Adv Gastroenterol. 2009. PMID: 21180581 Free PMC article.
-
A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy.Drugs. 1999 Jun;57(6):905-20. doi: 10.2165/00003495-199957060-00006. Drugs. 1999. PMID: 10400404 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical